Sixteen Swiss hospitals take part in coronavirus global Solidarity trial
University Hospital Lausanne is coordinating the trial in Switzerland.
Keystone / Laurent Gillieron
Some 1,000 patients in Switzerland are expected to participate in trials of experimental treatments for Covid-19 as part of the WHO global Solidarity trial.
Launched in March under the auspices of the World Health Organisation, the Solidarity trialExternal link aims to generate reliable data on the effectiveness and side effects of potential treatments.
While randomized clinical trials normally take years to design and conduct, the Solidarity trial is expected to reduce the time by 80% by enrolling patients in one single randomized trial. This will overcome the risk of multiple small trials not generating strong enough evidence.
The WHO has selected four therapies for testing based on laboratory, animal and clinical studies evidence of their potential to treat Covid-19. This includes remdesivir, chloroquine or hydroxychloroquine, lopinavir plus ritonavir, and interferon-beta. Novartis recently announced it was donating up to 130 million doses of the antimalarial drug hydroxychloroquine in part to advance clinical trials.
Switzerland is one of some 70 countries participating in the effort along with France, Spain, South Africa and Canada. The Swiss National Science Foundation (SNSF) has provided CHF1.6 million to the global trial and is working closely with the Federal Office of Public Health. Lausanne University Hospital CHUV is coordinating Switzerland’s participation in the tiral.
The sixteen hospital centres are the university hospitals of Lausanne, Geneva, Bern and Basel, the hospital networks of Valais and Neuchâtel, along with several cantonal hospitals. The hospitals are expected to recruit up to 1,000 patients to take part in the study according to a statementExternal link from CHUV.
The trial in Switzerland is expected to last from three months to one year but will depend in part on the evolution of the epidemic. The study may include up to 1,000 adult hospitalized patients who have not yet received treatment with Covid-19.
According to the WHOExternal link, patients diagnosed with COVID-19 and who have consented to be part of the study will be randomly selected to receive either local standard care alone or local standard care and one of a list of study drugs.
SNSF also announced that it has received 284 grant applicationsExternal link for its special call for coronavirus research issued in March. Funding decisions are expected to be communicated around mid-May 2020.
Living longer: What do you think about the longevity trend?
The longevity market is booming thanks in part to advances in the science of ageing. What do you think of the idea of significantly extending human lifespan?
Glacier collapses burying large parts of Swiss village Blatten
This content was published on
A gigantic avalanche of ice, mud and debris has buried a large part of the village of Blatten after a major glacier collapsed.
Swiss government seeks better labour integration of Ukrainian refugees
This content was published on
The Swiss government has now set a goal of 50% of Ukrainian refugees to be in employment by the end of 2025, compared with 38% at present.
Swiss government greenlights Ruag sale of Leopard tanks to Germany
This content was published on
The defence company Ruag MRO is allowed to sell 71 Leopard 1 battle tanks to Germany. However, the tanks may not be sold to Ukraine.
Foie gras sold in Switzerland must declare painful production process
This content was published on
Starting July 1, the sale of foie gras in Switzerland must make reference to the painful procedures performed on the animal.
Swiss economics minister seeks progress on US tariff negotiations by July
This content was published on
Swiss Economics Minister Guy Parmelin is hoping for results in the tariff negotiations with the US by the beginning of July.
UN weather agency expects new temperature record soon
This content was published on
A new global temperature record is likely to be set in the next five years, according to the World Meteorological Organisation in Geneva.
Geneva proposed as possible site for Ukraine-Russia talks
This content was published on
US special representative for Ukraine, Keith Kellogg, has said that Geneva is being considered as a venue for talks between Russia and Ukraine.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
WHO and Roche launch trials of potential coronavirus treatments
This content was published on
Roche is launching a clinical trial of a potential new Covid-19 drug, adding to rapidly growing investments in combating coronavirus.
Balancing hope and science in the search for a coronavirus cure
This content was published on
The debate surrounding the antimalarial drug hydroxychloroquine epitomises companies' balancing act between hope and scientific realities.
This content was published on
Swiss scientists and drug companies are playing an important role in the global effort to develop treatments or a vaccine for the virus.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.